Sheibani K, Nathwani B N, Swartz W G, Ben-Ezra J, Brownell M D, Burke J S, Kennedy J L, Koo C H, Winberg C D
James Irvine Center, City of Hope National Medical Center, Duarte, California 91010.
Cancer. 1988 Aug 15;62(4):657-64. doi: 10.1002/1097-0142(19880815)62:4<657::aid-cncr2820620402>3.0.co;2-m.
Eight hematopathologists independently reviewed 56 consecutive cases of benign and malignant lymphoproliferative disorders (LPD) to determine: (1) the degree of interobserver agreement on the interpretation of immunologic findings on fresh-frozen sections alone and on that of the immunologic findings in conjunction with corresponding hematoxylin and eosin (H & E)-stained histologic sections; (2) whether prior knowledge of morphologic characteristics influences the interpretation of immunohistologic sections; (3) whether immunologic phenotype could be predicted reliably based solely on study of histologic sections; and (4) the significance of immunologic data as an aid in the interpretation of histologic sections. The study was carried out in three independent review sessions consisting of (1) review of immunohistologic sections only, (2) review of the same immunohistologic sections together with histologic sections, and (3) review of the histologic sections alone. A consensus diagnosis was defined as agreement of five or more pathologists on the final diagnosis and identification of the immunophenotype. When the authors compared the total number of major disagreements in the first review session with those in the second, the accuracy of the determination of immunophenotype in the second session was clearly superior (P less than 0.05). Similarly, the total number of major disagreements in the second review session was significantly lower than that in the third review session (P less than 0.001). When histologic diagnoses in the second session were compared with those in the third session, it became apparent that the immunologic data helped the pathologist to correct major misinterpretations in 14 cases (25%). This study is the first to demonstrate quantitatively that (1) knowledge of morphologic features influences and greatly enhances the accuracy of the interpretation of immunologic findings, (2) the immunophenotype of LPD cannot be predicted based on morphologic findings alone, and (3) immunologic findings improve the accuracy of interpretation of histologic findings in situations in which a diagnosis cannot be made from morphologic features only.
八位血液病理学家独立回顾了连续的56例良性和恶性淋巴增殖性疾病(LPD),以确定:(1)仅根据新鲜冰冻切片以及结合相应苏木精和伊红(H&E)染色组织切片的免疫组化结果,观察者之间的一致性程度;(2)形态学特征的先验知识是否会影响免疫组织化学切片的解读;(3)是否仅通过组织切片研究就能可靠地预测免疫表型;以及(4)免疫数据在辅助解读组织切片中的意义。该研究分三个独立的回顾阶段进行,包括:(1)仅回顾免疫组织化学切片;(2)将相同的免疫组织化学切片与组织切片一起回顾;(3)仅回顾组织切片。共识诊断定义为五名或更多病理学家对最终诊断和免疫表型鉴定达成一致。当作者比较第一次回顾阶段与第二次回顾阶段的主要分歧总数时,第二次回顾阶段免疫表型确定的准确性明显更高(P<0.05)。同样,第二次回顾阶段的主要分歧总数明显低于第三次回顾阶段(P<0.001)。当比较第二次回顾阶段与第三次回顾阶段的组织学诊断时,明显发现免疫数据帮助病理学家在14例(25%)中纠正了主要的错误解读。本研究首次定量证明:(1)形态学特征的知识会影响并极大提高免疫组化结果解读的准确性;(2)仅根据形态学结果无法预测LPD的免疫表型;(3)在仅根据形态学特征无法做出诊断的情况下,免疫组化结果可提高组织学结果解读的准确性。